Recent Advances in Juvenile Dermatomyositis: Moving toward Integration of Myositis-Specific Antibody Clinical Phenotypes, IFN-Driven Pathogenesis, and Targeted Therapies
Journal of Investigative Dermatology · 2025-06 · 145 (6) · 1294-1304
DOI: 10.1016/j.jid.2024.09.017 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Investigative Dermatology, 2025-06. Verfasst von Kristen L Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA. Electronic address: kr…. Hauptthemen laut MEDLINE: Dermatomyositis, Autoantibodies, Interferon Type I. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 96 Literaturangaben. Gefördert von: National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health.
Abstract (Originalsprache)
Juvenile dermatomyositis (JDM), the most common pediatric inflammatory myopathy, is associated with significant morbidity despite therapeutic advances. Distinct clinical phenotypes have emerged, which can correlate with myositis-specific antibodies. Because translational data solidify the role of type I IFNs in JDM disease pathogenesis, integration of clinical and molecular phenotyping may impact the choice of targeted therapy. This paper reviews clinical and molecular phenotyping in JDM and translational insights into immune pathogenesis that have created emerging options for targeted therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, The School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA. Electronic address: kristenchen92@gmail.com.
- Division of Pediatric Dermatology, Department of Dermatology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA; Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
- Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Division of Allergy, Immunology and Rheumatology, Boston Children's Hospital, Harvard Medical School, Boston,…
- Division of Allergy, Immunology & Rheumatology, Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
- Juvenile Myositis Pathogenesis and Therapeutics Unit, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA.
- Division of Pediatric Rheumatology, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Förderung
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- National Institutes of Health
Zitieren
APA
Chen, K. L., Chiu, Y. E., Vleugels, R. A., Co, D. O., Kim, H., Sabbagh, S. E., & Arkin, L. M. (2025). Recent Advances in Juvenile Dermatomyositis: Moving toward Integration of Myositis-Specific Antibody Clinical Phenotypes, IFN-Driven Pathogenesis, and Targeted Therapies. Journal of Investigative Dermatology, 145(6), 1294-1304. https://doi.org/10.1016/j.jid.2024.09.017
Vancouver
Chen KL, Chiu YE, Vleugels RA, Co DO, Kim H, Sabbagh SE, et al. Recent Advances in Juvenile Dermatomyositis: Moving toward Integration of Myositis-Specific Antibody Clinical Phenotypes, IFN-Driven Pathogenesis, and Targeted Therapies. Journal of Investigative Dermatology. 2025;145(6):1294-1304. doi:10.1016/j.jid.2024.09.017
BibTeX
@article{Chen2025,
author = {Chen, Kristen L and Chiu, Yvonne E and Vleugels, Ruth Ann and Co, Dominic O and Kim, Hanna and Sabbagh, Sara E and Arkin, Lisa M},
title = {Recent Advances in Juvenile Dermatomyositis: Moving toward Integration of Myositis-Specific Antibody Clinical Phenotypes, IFN-Driven Pathogenesis, and Targeted Therapies},
journal = {Journal of Investigative Dermatology},
year = {2025},
volume = {145},
number = {6},
pages = {1294--1304},
doi = {10.1016/j.jid.2024.09.017}
}
EUVIMED